BeyondSpring Inc

BYSINASDAQ · USD
0.74USD0.00 (-1.31%)
112

BeyondSpring Inc (BYSI) Options Open Interest

BYSI options open interest is 814 contracts. The 2-week average daily volume is 29 contracts across the chain.

Read more

Monitoring BYSI open interest helps you see where real money is positioned on BeyondSpring Inc's options and which strikes are attracting the most commitment from traders. BeyondSpring Inc's open interest reflects the total number of outstanding contracts that have not been closed or exercised, making it a powerful gauge of liquidity, conviction, and potential support and resistance zones. Use our scanner to monitor BYSI options open interest in real time and find the strikes that matter.

Open interest is distinct from volume: volume counts how many contracts are traded in a session, while open interest counts how many remain open at the end of the day. Rising BYSI options open interest alongside rising volume suggests new positions are being built, while falling open interest signals positions are being closed. Heavy open interest at specific strikes often acts as a magnet near expiration and can hint at where dealers and large traders expect BeyondSpring Inc to settle.

BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer. It is also developing Plinabulin in combination with various immuno-oncology agents, including nivolumab, a PD-1 antibody for the treatment of NSCLC; nivolumab and ipilimumab, a CTLA-4 antibody for the treatment of SCLC; and in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers.

In addition, the company engages in the development of three small molecule immune agents in preclinical stages; and a drug development platform. The company was founded in 2010 and is headquartered in New York, New York.

Pin risk into expiration, dealer positioning, liquidity checks for large orders — all of it starts with knowing where BYSI open interest is concentrated. Our scanner maps BeyondSpring Inc's open interest across every strike and expiry, flags unusual buildups, and lets you drill into the contracts that institutional money is actually holding. Trade BeyondSpring Inc's options open interest as the signal it is, not as an afterthought.

2026-10-16
Calls
2.500.050.05332%+0.1921713
5.000.050.05440%+0.164628
7.500.050.05497%+0.15450
Puts
2.501.352.101.7355%-1.00000
5.003.604.804.2089%-1.00000
7.506.007.506.75427%-0.91760

As of September 18, 2026

Follow the money

Track BYSI open interest across every strike and expiration, identify where conviction is building, and trade with the positioning data on your side.

Start your 14-day free trial